BRPI1004898A2 - vetor expressão de superfície, microorganismo recombinate, vacina para tratar cervical e método para preparar um microorganismo - Google Patents

vetor expressão de superfície, microorganismo recombinate, vacina para tratar cervical e método para preparar um microorganismo

Info

Publication number
BRPI1004898A2
BRPI1004898A2 BRPI1004898A BRPI1004898A BRPI1004898A2 BR PI1004898 A2 BRPI1004898 A2 BR PI1004898A2 BR PI1004898 A BRPI1004898 A BR PI1004898A BR PI1004898 A BRPI1004898 A BR PI1004898A BR PI1004898 A2 BRPI1004898 A2 BR PI1004898A2
Authority
BR
Brazil
Prior art keywords
microorganism
recombinate
vaccine
cervical
preparing
Prior art date
Application number
BRPI1004898A
Other languages
English (en)
Inventor
Poo Haryoung
Han Lee Ii
Hee Sung Moon
Original Assignee
Bioleaders Corp
Kookmin Univ Industry Academic Cooperation Foundation
Korea Res Inst Bioscience & Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioleaders Corp, Kookmin Univ Industry Academic Cooperation Foundation, Korea Res Inst Bioscience & Biotechnology filed Critical Bioleaders Corp
Publication of BRPI1004898A2 publication Critical patent/BRPI1004898A2/pt
Publication of BRPI1004898B1 publication Critical patent/BRPI1004898B1/pt
Publication of BRPI1004898B8 publication Critical patent/BRPI1004898B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • C12N15/03—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/20045—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/55—Vectors comprising as targeting moiety peptide derived from defined protein from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI1004898A 2009-01-08 2010-01-08 vetor expressão de superfície, microorganismo recombinate, vacina para tratar cervical e método para preparar um microorganismo BRPI1004898B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020090001510A KR101471043B1 (ko) 2009-01-08 2009-01-08 안정적인 항시적 고발현 자궁경부암 치료백신용 벡터 및 그에 의해 형질전환된 재조합 유산균
KR102009001510 2009-01-08
PCT/KR2010/000126 WO2010079991A2 (ko) 2009-01-08 2010-01-08 안정적인 항시적 고발현 자궁경부암 치료백신용 벡터 및 그에 의해 형질전환된 재조합 유산균

Publications (3)

Publication Number Publication Date
BRPI1004898A2 true BRPI1004898A2 (pt) 2017-12-12
BRPI1004898B1 BRPI1004898B1 (pt) 2020-10-13
BRPI1004898B8 BRPI1004898B8 (pt) 2021-05-25

Family

ID=40791853

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1004898A BRPI1004898B8 (pt) 2009-01-08 2010-01-08 vetor expressão de superfície, microorganismo recombinate, vacina para tratar cervical e método para preparar um microorganismo

Country Status (12)

Country Link
US (1) US8685721B2 (pt)
EP (1) EP2386645B1 (pt)
JP (1) JP5536803B2 (pt)
KR (1) KR101471043B1 (pt)
CN (1) CN102341499B (pt)
BR (1) BRPI1004898B8 (pt)
ES (1) ES2513440T3 (pt)
GB (1) GB2466856B (pt)
MX (1) MX2011007307A (pt)
PL (1) PL2386645T3 (pt)
RU (1) RU2492240C2 (pt)
WO (1) WO2010079991A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2493846C1 (ru) * 2012-02-03 2013-09-27 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Минздравсоцразвития России Способ лечения местно-распространенного рака влагалища
JP2014210747A (ja) 2013-04-19 2014-11-13 アンジェスＭｇ株式会社 細胞性免疫誘導能が改善された経口ワクチン
ES2876036T3 (es) * 2015-01-30 2021-11-11 Univ Tokyo Composición que contiene una bacteria láctica, composición farmacéutica oral para su uso en el tratamiento de infecciones por VPH y/o tumores asociados a VPH y agente inductor de inmunidad de la mucosa para su uso en dotar de inmunidad mucosal contra la infección por VPH
KR20200000972A (ko) * 2018-06-26 2020-01-06 주식회사 바이오리더스 바실러스 속 균주 유래의 폴리감마글루탐산 합성유전자를 이용한 표면발현벡터 및 이를 이용한 단백질의 미생물표면 발현 방법
EP3940077B1 (en) 2018-10-10 2025-01-01 Bioleaders Corporation Surface expression vector using two kinds of promoters derived from lactobacillus casei for concurrently expressing two target proteins and method for expressing proteins on microbial surface by using same
CN113330119B (zh) * 2018-10-10 2024-07-12 生物领先公司 使用源自干酪乳杆菌的半乳糖变旋酶基因启动子用于组成型高表达的表面表达载体及其用途
US11037655B2 (en) 2019-10-16 2021-06-15 University Of Maryland, Baltimore Microbiome-based informed method to formulate live biotherapeutics
US10967012B2 (en) 2019-10-16 2021-04-06 University Of Maryland, Baltimore Microbiome-based informed method to formulate live biotherapeutics
WO2022103126A1 (ko) * 2020-11-10 2022-05-19 주식회사 바이오리더스 코로나바이러스의 스파이크 단백질 및 뉴클레오캡시드 단백질을 동시발현하는 복제불능 아데노바이러스를 이용한 코로나바이러스 백신
KR102882279B1 (ko) * 2022-05-09 2025-11-10 주식회사 모아라이프플러스 코로나바이러스의 스파이크 단백질, 뉴클레오캡시드 단백질 및 PgsA 단백질을 동시발현하는 복제불능 아데노바이러스를 이용한 코로나바이러스 백신

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888516A (en) * 1994-05-16 1999-03-30 Merck & Co. Inc. Recombinant papillomavirus vaccines
FI105105B (fi) * 1998-02-27 2000-06-15 Finnish Immunotechnology Ltd O Itsereplikoiva DNA-vektori immunisoimiseksi HIV:ta vastaan
FR2794370B1 (fr) 1999-06-03 2003-10-17 Biovector Therapeutics Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination
KR100366608B1 (ko) 2000-02-15 2003-01-09 마스터진(주) 형질전환 식물체로부터 생산된 재조합 인간 파필로마바이러스 백신
JP4458844B2 (ja) * 2001-08-10 2010-04-28 バイオリーダース・コーポレイション ｐｇｓＢＣＡ、ポリ−γ−グルタミン酸シンテターゼをコードする遺伝子を有する表面発現用のベクター、及びこれを用いた標的タンパク質の微生物表面発現方法
JP4549858B2 (ja) * 2002-10-17 2010-09-22 バイオリーダーズ コーポレイション ヒト・パピローマウイルスに対するワクチン用ベクターおよび同ベクターによって形質転換された微生物
US9701725B2 (en) * 2003-05-05 2017-07-11 The Johns Hopkins University Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
KR100872042B1 (ko) * 2005-09-14 2008-12-05 주식회사 바이오리더스 마이오스타틴을 발현하는 세포표면 발현벡터 및 상기벡터에 의해 형질전환된 미생물
KR100972843B1 (ko) * 2007-03-22 2010-07-28 주식회사 바이오리더스 신규 항시적 고발현 프로모터 및 그 용도
KR101564084B1 (ko) * 2009-01-08 2015-10-29 주식회사 바이오리더스 ｒｅｐＥ 변이유전자를 함유하는 항시적 고발현 벡터

Also Published As

Publication number Publication date
JP2012514469A (ja) 2012-06-28
US8685721B2 (en) 2014-04-01
EP2386645A2 (en) 2011-11-16
KR20100082155A (ko) 2010-07-16
CN102341499B (zh) 2014-05-28
BRPI1004898B1 (pt) 2020-10-13
GB2466856A (en) 2010-07-14
ES2513440T3 (es) 2014-10-27
CN102341499A (zh) 2012-02-01
RU2011133057A (ru) 2013-03-20
EP2386645B1 (en) 2014-07-16
WO2010079991A2 (ko) 2010-07-15
RU2492240C2 (ru) 2013-09-10
EP2386645A4 (en) 2012-12-26
GB0907207D0 (en) 2009-06-10
WO2010079991A3 (ko) 2010-11-18
GB2466856B (en) 2011-06-01
US20110318384A1 (en) 2011-12-29
PL2386645T3 (pl) 2015-01-30
KR101471043B1 (ko) 2014-12-09
JP5536803B2 (ja) 2014-07-02
BRPI1004898B8 (pt) 2021-05-25
MX2011007307A (es) 2011-09-21

Similar Documents

Publication Publication Date Title
BRPI1004898A2 (pt) vetor expressão de superfície, microorganismo recombinate, vacina para tratar cervical e método para preparar um microorganismo
PT2448734T (pt) Pré-forma, recipiente e método para a formação de um recipiente
BRPI1007709A2 (pt) "artigo e método para a preparação de um artigo"
BRPI1010255A2 (pt) "método e dispositivo para preparação de estoque de laminação a quente."
BR112012006415A2 (pt) método para preparar vlps derivadas de plantas
BRPI0907391A2 (pt) Método para a preparação de um formador de escória espumante, produto e uso do mesmo
BR112012000906A2 (pt) dispositivo de recipiente revestido, método para preparar um dispositivo de recipiente revestido, dispositivo de fechamento revestido e método para preparar um dispositivo de fechamento revestido
ZA201202758B (en) Stabilising excipient for inactivated whole-virus vaccines
EP2762325A4 (en) IMAGE FORMATION METHOD AND COMBINATION OF THERMAL TRANSFER SHEET AND THERMAL TRANSFER IMAGE RECEPTION SHEET
BRPI1016215A8 (pt) processo para a preparação de um comprimido de desintegração rápida, sistema para realizar um processo, e, embalagem.
IL231991A0 (en) Support and capsule for preparing a beverage by centrifugation, system and method for preparing a beverage by centrifugation
IL231990A0 (en) Support and capsule for preparing a beverage by centrifugation, system and method for preparing a beverage by centrifugation
BR112013007397A2 (pt) sistema para a autenticação, método para a autenticação, e método para permitir a autenticação,
BRPI1008643B8 (pt) recheio alimentício cremoso, e, método para formar um recheio alimentício cremoso
BR112013011052A2 (pt) método para utilizar realimentação de usuário de um dispositivo de usuário, e, dispositivo de usuário
BRPI1014035A2 (pt) método para contracepção.
BR112014004388A2 (pt) estrutura de segurança, documento e método para autenticar um documento
BR112013023471A2 (pt) cocristal de n-[2-(7-metóxi-1-naftil) etil]acetamina, e, processo para preparar um cocristal.
ZA201206765B (en) Positioning apparatus,working system,and hot working apparatus
BRPI0924981A2 (pt) vacinas para câncer cervical.
BR112012001462A2 (pt) processo para preparar metil mercaptano.
SI2396030T1 (sl) Sheme dajanja cepiva proti gripi za seve, povezane s pandemijo
BR112014013188A2 (pt) documento de segurança, e método para fabricar um documento de segurança
PL2782754T3 (pl) Arkusz, sposób wytwarzania i zastosowanie arkusza jako wieczka do opakowań
BR112013014312A2 (pt) peça em bruto de armação interna para recipiente, recipiente, uso da armação interna e método para aumentar a estabilidade do recipiente

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: BIOLEADERS CORPORATION (KR) , KOREA RESEARCH INSTI

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: BIOLEADERS CORPORATION (KR) , KOOKMIN UNIVERSITY I

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: BIOLEADERS CORPORATION (KR)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/01/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2862 DE 11-11-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.